Question 1

What is Thymalin?

Accepted Answer

Thymalin is a peptide extract from the thymus gland, developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is one of the foundational Khavinson bioregulators and has been studied in large-scale human trials spanning 6-8 years involving hundreds of elderly patients.

Question 2

What are the research benefits of Thymalin?

Accepted Answer

Research on Thymalin has investigated its potential effects in several areas, including: Studied in large human trials (266 elderly patients, 6-8 year follow-up); Khavinson data shows improved immune function and reduced mortality in elderly; Researched for thymic rejuvenation and immune restoration; May restore T-cell function that declines with aging. These findings are primarily from preclinical and animal studies unless otherwise noted. Results may not translate directly to humans.

Question 3

How does Thymalin work?

Accepted Answer

Thymalin acts as a thymic hormone replacement, restoring T-cell maturation and differentiation that declines with age-related thymic involution. It modulates the ratio of T-helper to T-suppressor cells, enhances natural killer cell activity, and normalizes cytokine profiles. In the Khavinson framework, it is classified as a bioregulator that restores gene expression patterns in thymic tissue to a more youthful state.

Question 4

What is the FDA/legal status of Thymalin?

Accepted Answer

Thymalin is currently in clinical trials and is not yet FDA-approved for general use. It may only be used in the context of approved clinical trial protocols. It is not available for general consumer purchase in the United States.

Question 5

What are the known risks or side effects of Thymalin?

Accepted Answer

Based on available research, Thymalin has been associated with the following in study settings: Generally well-tolerated in clinical studies; Injection site reactions; Allergic reactions (rare — derived from animal tissue); Limited Western clinical data. Long-term safety data in humans is limited or absent for most research peptides. This should not be taken as a complete safety profile.

Question 6

Where can I find published research on Thymalin?

Accepted Answer

Published research on Thymalin can be found on PubMed (pubmed.ncbi.nlm.nih.gov). Search for "Thymalin" or its aliases (Thymic peptide extract, Thymus bioregulator) to find peer-reviewed studies. PEP.WIKI aggregates key studies with abstracts and study type classifications on each compound's research page.

Thymalin

Overview

Mechanism of Action

Key Research Benefits

Clinical Evidence Summary

Key Studies / PubMed References

Expression features of T-lymphocytes, B-lymphocytes and macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding soft tissues.

Reparative osteogenesis in mandible in cases of filling a bone defect with hydroxyapatite-containing osteotropic material and injecting the surrounding soft tissues with thymalin: experimental and morphological study.

The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19.

[Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin.].

Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.

Side Effects & Safety

Known Interactions

Frequently Asked Questions

Research Disclaimer